Description
What it is
Proprietary co-formulation of BPC-157 and TB-500 in a single vial for streamlined research protocols.
Mechanism
Combined formulation leveraging the angiogenic action of BPC-157 with the cell-migration effects of TB-500.
Specifications
- Peptide content: 10mg / vial
- HPLC purity: ≥99.6%
- Form: Lyophilized powder
- Storage: 2–8°C, protected from light
- Shipping: Cold-chain dispatch from EU warehouse, same-day if ordered before 14:00 CET
Certificate of Analysis
Every batch ships with a downloadable Certificate of Analysis showing HPLC purity, mass-spec identity confirmation, and microbial/endotoxin pass results.






Reviews
There are no reviews yet.